BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33628849)

  • 1. CDK12 Promotes Cervical Cancer Progression through Enhancing Macrophage Infiltration.
    Yang B; Chen J; Teng Y
    J Immunol Res; 2021; 2021():6645885. PubMed ID: 33628849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer.
    Yang B; Chen J; Teng Y
    J Immunol Res; 2021; 2021():9994004. PubMed ID: 33987449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell-derived exosomes deliver TIE2 protein to macrophages to promote angiogenesis in cervical cancer.
    Du S; Qian J; Tan S; Li W; Liu P; Zhao J; Zeng Y; Xu L; Wang Z; Cai J
    Cancer Lett; 2022 Mar; 529():168-179. PubMed ID: 35007697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
    Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
    Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p.
    Lin L; Xin B; Jiang T; Wang XL; Yang H; Shi TM
    Mol Cell Biochem; 2020 Dec; 475(1-2):1-13. PubMed ID: 32740791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA‑130a‑3p promotes the proliferation and inhibits the apoptosis of cervical cancer cells via negative regulation of RUNX3.
    Wang M; Wang X; Liu W
    Mol Med Rep; 2020 Oct; 22(4):2990-3000. PubMed ID: 32945424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS1-ErbB-PI3K signaling.
    Choi HJ; Jin S; Cho H; Won HY; An HW; Jeong GY; Park YU; Kim HY; Park MK; Son T; Min KW; Jang KS; Oh YH; Lee JY; Kong G
    EMBO Rep; 2019 Oct; 20(10):e48058. PubMed ID: 31468695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration-resistant prostate cancer.
    Zhang H; Zhou Y; Feng Y; Hou W; Chen Y; Xing Z; Zhang Y; Wei Q; Yin Y; Guo J; Hu H
    Clin Transl Med; 2024 May; 14(5):e1678. PubMed ID: 38736108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK12 loss inhibits cell proliferation by regulating TBK1 in non-small cell lung cancer cells.
    Liu X; Liu Y; Chai W; Yan M; Li H; Li J; Sun L; Cao Y; Liu Q; Sun Y; Pan H
    Mol Cell Probes; 2023 Oct; 71():101923. PubMed ID: 37517598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
    Xu R; Chen L; Yang WT
    Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cells induce LAMP2a expression in tumor-associated macrophage for cancer progression.
    Wang R; Liu Y; Liu L; Chen M; Wang X; Yang J; Gong Y; Ding BS; Wei Y; Wei X
    EBioMedicine; 2019 Feb; 40():118-134. PubMed ID: 30711520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
    Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
    Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
    Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
    Zhu Z; Hou Q; Guo H
    Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK12 and PAK2 as novel therapeutic targets for human gastric cancer.
    Liu H; Shin SH; Chen H; Liu T; Li Z; Hu Y; Liu F; Zhang C; Kim DJ; Liu K; Dong Z
    Theranostics; 2020; 10(14):6201-6215. PubMed ID: 32483448
    [No Abstract]   [Full Text] [Related]  

  • 17. CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-tyrosine kinase inhibitor via suppressing PI3K/AKT.
    Li H; Wang J; Yi Z; Li C; Wang H; Zhang J; Wang T; Nan P; Lin F; Xu D; Qian H; Ma F
    Eur J Cancer; 2021 Mar; 145():92-108. PubMed ID: 33429148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
    Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y
    Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer.
    Luo Q; Zheng N; Jiang L; Wang T; Zhang P; Liu Y; Zheng P; Wang W; Xie G; Chen L; Li D; Dong P; Yuan X; Shen L
    Cancer Sci; 2020 Nov; 111(11):4000-4011. PubMed ID: 32798273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
    Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
    IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.